Your gift is 100% tax deductible.
Treatment Options for Oropharyngeal Cancer by Stage
Treatment for oropharyngeal cancer is based largely on the stage (extent) of the cancer and if it is caused by an HPV infection (p16-positive), but other factors can also be important.
Most experts agree that treatment in a clinical trial should be considered for any cancer in the head and neck areas. A clinical trial might offer a chance to get new treatments that could be better than standard ones.
This information is based on AJCC staging systems prior to 2018, which were primarily based on tumor size and lymph node status. Because the updated staging system for oropharyngeal cancer now also includes the p16 (HPV) status of the tumor, the stages may be higher or lower than with previous staging systems.
Treatment strategies are slowly changing with this new staging system, so you should discuss your stage and treatment options with your cancer care team.
Stage 0 (carcinoma in situ) oropharyngeal cancer
Cancer in this stage is on the surface layer and hasn’t started to grow into deeper layers of tissue, but it can do so if it isn’t treated.
The usual treatment is surgery to remove the top layers of tissue along with a small margin (edge) of normal tissue. This is generally Mohs surgery, surgical stripping, or thin resection.
Close follow-up is important to watch for any signs that the cancer has come back. Carcinoma in situ that keeps coming back after surgery may need to be treated with radiation therapy.
Early-stage oropharyngeal cancer
Early-stage oropharyngeal cancers (back of the tongue, soft palate, and tonsils) typically include most stage I and II cancers, p16/HPV-positive or p16/HPV-negative.
The main treatment options include:
- Radiation therapy aimed at the cancer and lymph nodes in the neck, or
- Surgery of the main tumor along with removal of the lymph nodes in the neck (lymph node dissection)
After surgery, if any cancer remains or if there is a high chance of the cancer coming back, chemoradiation is often used.
Sometimes, if imaging or a biopsy shows the lymph nodes in the neck have cancer, chemoradiation might be the first treatment.
Locally advanced oropharyngeal cancer
These are larger cancers in the back of the tongue, soft palate, and tonsils that have grown into nearby tissues, and/or have spread to nearby lymph nodes in the neck.
In general, this includes most stage III, IVA, and IVB p16/HPV-negative cancers and most stage I, II, and III p16/HPV-positive cancers in the TNM system.
- Most locally advanced oropharyngeal cancers are treated with chemoradiation.
- Any cancer that is still present after chemoradiation is often removed with surgery.
- Sometimes, chemo might be given as the first treatment, followed by radiation alone or chemoradiation, and then surgery if needed.
Surgery might also be an option as the first treatment if the surgeon thinks the cancer can be removed safely. If surgery is planned, immunotherapy with a drug called a checkpoint inhibitor might be given both before and after surgery. Radiation or chemoradiation might be given after surgery as well.
The choice of treatment is often guided by the location of the cancer, how much it has spread, the expected side effects, and a person's current health and preferences.
If the cancer has spread to neck lymph nodes, these might also need to be removed with a lymph node dissection.
Metastatic oropharyngeal cancer
Metastatic oropharyngeal cancers (back of the tongue, soft palate, and tonsils) include stage IVC p16/HPV-negative cancers and stage IV p16/HPV-positive cancers that have spread to other parts of the body, such as the lungs.
- These cancers are usually treated with chemo, the targeted drug cetuximab, or both.
- Immunotherapy, alone or with chemo, might be another option.
Treatments such as radiation may also be used to help relieve symptoms from the cancer or help prevent new problems.
Recurrent oropharyngeal cancer
When cancer comes back after treatment, it's called recurrent cancer. It can:
- Come back in or near the same place it first started (local)
- Come back in nearby lymph nodes (regional)
- Spread to other organs such as the lungs or bone (distant)
Treatment options for recurrent oropharyngeal cancers depend on the location and size of the cancer, what treatments have already been used, and a person’s general health. Because these cancers can be hard to treat, clinical trials of newer treatments may be a good option for some people.
Local recurrence
If the cancer comes back in the same area and radiation therapy was used as the first treatment, surgery is often the next treatment if the cancer can be removed completely and the person is healthy enough for surgery.
Usually, external beam radiation therapy can’t be repeated in the same site except in certain cases. But internal radiation (brachytherapy) can often be used to control the cancer if it comes back in the place it started.
If surgery was used first, more surgery, radiation therapy, chemo, the targeted drug cetuximab, immunotherapy, or a combination of these may be an option.
Regional recurrence
If the cancer comes back in the lymph nodes in the neck, the nodes are often removed with surgery (lymph node dissection). This may be followed by radiation or chemoradiation.
Distant recurrence
If the cancer comes back in a distant area, chemo (and/or cetuximab) is often used. Immunotherapy with or without chemo might be an option as well. Treatment might shrink or slow the growth of some cancers for a while and help relieve symptoms, but these cancers are very hard to cure.
If further treatment is recommended, it’s important to talk to your cancer care team so you understand the goal of treatment. Ask whether the goal is to try to cure the cancer or to relieve symptoms and keep the cancer under control for as long as possible. This can help you weigh the risks and benefits of each option.
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
National Cancer Institute. Oropharyngeal Cancer Treatment (Adult) (PDQ)–Health Professional Version. May 14, 2025. Accessed at www.cancer.gov/types/head-and-neck/hp/adult/oropharyngeal-treatment-pdq on February 9, 2026.
National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology (NCCN Guidelines), Head and Neck Cancers, V.1.2026. Accessed at www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf on February 3, 2026.
Last Revised: March 23, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.


